Login
$INCY
$116.77 -$0.10 (0.09%) Live

Company Executives

Management Team

From the 10-K annual report
Officer Age In this role Joined 2025 pay Source
William J. Meury Also a director
President and Chief Executive Officer
57 Since 2025
1 year
2025 $32,085,952
Suketu Upadhyay
EVP & Chief Financial Officer
Title from the Form 4 dated May 4, 2026
Not stated Not stated Not stated Not reported
Soni Basi
Executive Vice President and Chief Human Resources Officer (CHRO)
51 Since 2025
1 year
2025 Not reported
David Gardner
Executive Vice President and Chief Strategy Officer
43 Since 2025
1 year
2025 Not reported
Richard Hoffman
Executive Vice President and General Counsel
64 Since 2025
1 year
2025 Not reported
Patrick A Mayes
EVP & Chief Scientific Officer
Title from the Form 4 dated Aug 5, 2026
Not stated Not stated Not stated Not reported
Pablo J. Cagnoni
President, Global Head of R&D
Title from the Form 4 dated Oct 15, 2026
63 Not stated 2023 $8,838,961
Steven Stein
CMO & Head of Late-Stage Dev.
Title from the Form 4 dated Jul 16, 2026
59 Not stated 2015 $6,304,172
Lee Heeson
Executive Vice President, Incyte International
55 Since 2024
2 years
2024 Not reported
Mohamed Issa
EVP, Head of U.S. Commercial
Title from the Form 4 dated Jul 16, 2026
43 Not stated 2025 $10,592,782
Michael Morrissey
EVP, Head of Tech. Operations
Title from the Form 4 dated Jul 23, 2026
62 Not stated 2016 Not reported
Matteo Trotta
Executive Vice President, General Manager, Dermatology US
47 Since 2024
2 years
2024 Not reported
Ramitpal K Basi
EVP, Human Resources
Title from the Form 4 dated Aug 25, 2026
Not stated Not stated Not stated Not reported
Thomas Tray
Principal Accounting Officer
Title from the Form 4 dated Jul 16, 2026
Not stated Not stated Not stated $990,368

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
8
serving now
Independent
6 of 7
stated in the proxy; 1 not stated
Average tenure
9.4 years
from year joined
CEO also chairs the board
No
Julian C. Baker
Director Age On board Independent Committees Other public boards 2025 pay Source
Julian C. Baker
59 2001
25 years
Not stated
Nominating and Corporate Governance · Chair Compensation
Acadia Pharmaceuticals Inc., Madrigal Pharmaceuticals, Inc., Denali Therapeutics Inc. $573,138
William J. Meury
58 2025
1 year
Not independent None stated None stated Paid as CEO
Jean-Jacques Bienaimé
72 2015
11 years
Independent
Compensation · Chair Nominating and Corporate Governance
Immunome, Inc., Keros Therapeutics, Inc., Ascendis Pharma A/S $536,138
Otis W. Brawley
66 2021
5 years
Independent
Science and Technology
Agilent Technologies, Inc., Lyell Immunopharma, Inc., PDS Biotechnology Corporation $511,138
Paul J. Clancy
64 2015
11 years
Independent
Audit and Finance · Chair Compensation
Sionna Therapeutics, Inc. $538,138
Jacqualyn A. Fouse
64 2017
9 years
Independent
Audit and Finance Nominating and Corporate Governance
Agios Pharmaceuticals, Inc., Madrigal Pharmaceuticals, Inc. $524,638
Edmund P. Harrigan
73 2019
7 years
Independent
Science and Technology · Chair Audit and Finance
Acadia Pharmaceuticals Inc. $539,638
Katherine A. High
74 2020
6 years
Independent
Science and Technology
CRISPR Therapeutics AG $511,138

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 28, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support